Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Olumide B. Gbolahan, MBBS, MSc
Emory University Hospital/Winship Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
Recruiting - Emory University Hospital
Atlanta, Georgia, United States
Olumide B. Gbolahan, MBBS, MScRecruiting - Emory University Hospital Midtown
Atlanta, Georgia, United States
Recruiting - Emory Decatur Hospital
Decatur, Georgia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Apr 2026
- Primary completion
- 18 Dec 2028
- Completion
- 18 Dec 2029
- Last update posted
- 17 Apr 2026
- Registered enrollment
- 38
- Registry id
- NCT07405476
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.